2005
Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study
Modi W, Scott K, Goedert J, Vlahov D, Buchbinder S, Detels R, Donfield S, O'Brien S, Winkler C. Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study. Genes & Immunity 2005, 6: 691-698. PMID: 16177829, DOI: 10.1038/sj.gene.6364258.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdolescentAdultAllelesBlack or African AmericanChemokine CXCL12Chemokines, CXCChildCohort StudiesDisease ProgressionFemaleGene FrequencyHaplotypesHIV InfectionsHIV-1HumansLongitudinal StudiesMaleOdds RatioPolymorphism, Single NucleotideRisk FactorsSurvival AnalysisUnited StatesWhite PeopleConceptsSDF-1 geneCohort studySingle nucleotide polymorphismsAfrican AmericansOnly natural ligandSingle disease outcomesX4 HIV-1HIV-1 infectionAIDS Cohort StudyRisk of infectionMACS cohortDisease outcomeHIV-1Epidemiological studiesSDF-1Significant associationChemokine genesInfectionRs1801157Natural ligandProgressionHaplotype analysisCommon haplotypeCXCR4Cohort
2004
MICA and recovery from hepatitis C virus and hepatitis B virus infections
Karacki P, Gao X, Thio C, Thomas D, Goedert J, Vlahov D, Kaslow R, Strathdee S, Hilgartner M, O'Brien S, Carrington M. MICA and recovery from hepatitis C virus and hepatitis B virus infections. Genes & Immunity 2004, 5: 261-266. PMID: 15029237, DOI: 10.1038/sj.gene.6364065.Peer-Reviewed Original ResearchConceptsHepatitis C virusHepatitis B virus infectionChronic hepatitis BB virus infectionHepatitis BC virusVirus infectionMICA polymorphismNatural killer cellsHBV infectionHCV infectionHepatitis CKiller cellsViral clearanceViral persistenceT cellsStudy populationMICA allelesSignificant associationInfectionFurther investigationVirusAssociationPersonsDifferential distribution
2002
Drug Dependence among Young Recently Initiated Injection Drug Users
Arria A, Fuller C, Strathdee S, Latkin C, Vlahov D. Drug Dependence among Young Recently Initiated Injection Drug Users. Journal Of Drug Issues 2002, 32: 1089-1102. DOI: 10.1177/002204260203200405.Peer-Reviewed Original ResearchInjection drug usersDrug usersDrug dependenceYoung injection drug usersCurrent drug dependenceDSM-IV criteriaDrug treatmentDrug useSignificant associationSociodemographic characteristicsCommunity settingsMeet criteriaDrug abuseNational Household SurveyHeroinCocaineHigher proportionMalesAssociationHousehold surveyPrevalenceProportion
1992
Prognostic indicators for development of AIDS among intravenous drug users.
Muñoz A, Vlahov D, Solomon L, Margolick J, Bareta J, Cohn S, Astemborski J, Nelson K. Prognostic indicators for development of AIDS among intravenous drug users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1992, 5: 694-700. PMID: 1613668.Peer-Reviewed Original ResearchConceptsCD4 cell countIntravenous drug usersClinical symptomsDrug usersCell countHigher CD4 cell countsHIV-1-related symptomsSeropositive intravenous drug usersPneumocystis carinii prophylaxisIntravenous drug useDevelopment of AIDSDose-response relationshipYear of enrollmentSerum neopterinLaboratory markersSerum betaPrognostic indicatorClinical evaluationAntiviral agentsRelative hazardDrug useSurvival analysisMultivariate analysisSignificant associationAIDS
1991
Sexually Transmitted Diseases in a Population of Intravenous Drug Users: Association with Seropositivity to the Human Immunodeficiency Virus (HIV)
Nelson K, Vlahov D, Cohn S, Odunmbaku M, Lindsay A, Anthony J, Hook E. Sexually Transmitted Diseases in a Population of Intravenous Drug Users: Association with Seropositivity to the Human Immunodeficiency Virus (HIV). The Journal Of Infectious Diseases 1991, 164: 457-463. PMID: 1869836, DOI: 10.1093/infdis/164.3.457.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virusHistory of syphilisHIV seropositivityDrug usersMultivariate analysisHeterosexual intravenous drug usersHuman immunodeficiency virus seropositivityMale intravenous drug usersEvidence of STDUnsafe sex practicesDrug use practicesHIV seroprevalenceHIV infectionImmunodeficiency virusVirus seropositivityPhysical examinationSexual transmissionCocaine injectionSeropositivitySex partnersSignificant associationSex practicesBisexual menSexual intercourse
1990
Coinfection with tuberculosis and HIV-1 in male prison inmates.
Salive M, Vlahov D, Brewer T. Coinfection with tuberculosis and HIV-1 in male prison inmates. Public Health Reports 1990, 105: 307-10. PMID: 2113691, PMCID: PMC1580008.Peer-Reviewed Original ResearchConceptsHIV-1HIV-1 antibody testingHuman immunodeficiency virus type 1Latent HIV-1 infectionImmunodeficiency virus type 1HIV-1 infectionVirus type 1Case-control designAnergy testingTB infectionAntibody testingMantoux testingElevated riskSignificant associationPast exposureTuberculosisType 1InfectionState prison systemMale prison inmatesAssociationPrison inmatesMale inmatesIntake samplesAdmission